Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 0.978 | 9 | 8 | 2007 | 2019 | |||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.958 | 7 | 8 | 1988 | 2019 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.500 | None | 1.000 | 5 | 1 | 2011 | 2019 | ||||||||
|
switching B cell complex subunit SWAP70 | 0.736 | 0.385 | 5.0E-02 |
|
disease | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2018 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 2 | 0.656 | 0.577 | 1.00 |
|
disease | 0.140 | None | 1.000 | 4 | 3 | 2008 | 2018 | ||||||||
|
phospholipid phosphatase 3 | 0.722 | 0.192 | 0.92 |
|
disease | 0.490 | None | 1.000 | 4 | 6 | 2011 | 2019 | ||||||||
|
mortality factor 4 like 1 | 0.736 | 0.423 | 0.99 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2013 | 2018 | ||||||||
|
guanylate cyclase 1 soluble subunit alpha 1 | 0.686 | 0.577 | 3.1E-08 |
|
disease | 0.450 | None | 1.000 | 4 | 5 | 2012 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.180 | None | 1.000 | 4 | 2 | 1998 | 2018 | ||||||||
|
junctional cadherin 5 associated | 0.751 | 0.269 | 3.0E-03 |
|
disease | 0.470 | None | 1.000 | 4 | 3 | 2011 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.500 | None | 0.918 | 4 | 1 | 1996 | 2020 | ||||||||
|
cadherin 13 | 0.501 | 0.846 | 7.1E-04 |
|
disease | 0.110 | None | 1.000 | 4 | 1 | 2015 | 2018 | ||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2017 | 2018 | |||||||||
|
TCF21 antisense RNA inducing promoter demethylation | 0.821 | 0.308 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2015 | 2018 | |||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
disease | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
MIA SH3 domain ER export factor 3 | 0.716 | 0.423 | 3.7E-02 |
|
disease | 0.440 | None | 1.000 | 4 | 5 | 2011 | 2019 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
disease | 0.140 | None | 1.000 | 3 | 5 | 2011 | 2018 | ||||||||
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 1.000 | 3 | 4 | 2017 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1312 | 0.931 | 0.077 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2015 | 2018 | |||||||||
|
lipase A, lysosomal acid type | 0.564 | 0.654 | 5.5E-07 |
|
disease | 0.450 | None | 1.000 | 3 | 2 | 2003 | 2019 | ||||||||
|
nitric oxide associated 1 | 0.821 | 0.192 | 9.6E-06 |
|
disease | 0.100 | None | 1.000 | 3 | 3 | 2015 | 2018 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.130 | None | 1.000 | 3 | 3 | 2014 | 2018 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2017 | 2018 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
disease | 0.100 | None | 1.000 | 3 | 2 | 2013 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.500 | None | 0.900 | 3 | 2 | 2010 | 2019 |